Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anis Askarizadeh, Ali Badiee & Ali Khamesipour. (2020) Development of nano-carriers for Leishmania vaccine delivery. Expert Opinion on Drug Delivery 17:2, pages 167-187.
Read now
Read now
Delaram Doroud & Sima Rafati. (2012) Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems. Expert Review of Vaccines 11:1, pages 69-86.
Read now
Read now
Articles from other publishers (15)
João A. Oliveira-da-Silva, Amanda S. Machado, Fernanda F. Ramos, Grasiele S.V. Tavares, Daniela P. Lage, Débora V.C. Mendonça, Isabela A.G. Pereira, Thaís T.O. Santos, Vívian T. Martins, Lívia M. Carvalho, Camila S. Freitas, Fernanda Ludolf, Thiago A.R. Reis, Raquel S. Bandeira, Alessandra M. Silva, Lourena E. Costa, Jamil S. Oliveira, Mariana C. Duarte, Bruno M. Roatt, Antônio L. Teixeira & Eduardo A.F. Coelho. (2020) A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis. Cellular Immunology 356, pages 104194.
Crossref
Crossref
Patrícia A.F. Ribeiro, Daniel S. Dias, Marcus V.M. Novais, Daniela P. Lage, Grasiele S.V. Tavares, Débora V.C. Mendonça, Jamil S. Oliveira, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Mariana C. Duarte, Daniel Menezes-Souza, Fernanda Ludolf, Carlos A.P. Tavares, Mônica C. Oliveira & Eduardo A.F. Coelho. (2018) A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis. Cytokine 111, pages 131-139.
Crossref
Crossref
Anis Askarizadeh, Mahmoud Reza Jaafari, Ali Khamesipour & Ali Badiee. (2017) Liposomal adjuvant development for leishmaniasis vaccines. Therapeutic Advances in Vaccines 5:4-5, pages 85-101.
Crossref
Crossref
Lilian S. Medina, Bruno Araújo Souza, Adriano Queiroz, Luiz Henrique Guimarães, Paulo Roberto Lima Machado, Edgar M Carvalho, Mary Edythe Wilson & Albert Schriefer. (2016) The gp63 Gene Cluster Is Highly Polymorphic in Natural Leishmania (Viannia) braziliensis Populations, but Functional Sites Are Conserved. PLOS ONE 11:9, pages e0163284.
Crossref
Crossref
Fatemeh Fakhraee, Ali Badiee, Seyedeh Hoda Alavizadeh, Seyed Amir Jalali, Omid Chavoshian, Ali Khamesipour, Fereidoun Mahboudi & Mahmoud Reza Jaafari. (2016) Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB/c mice-based experimental setting. Acta Tropica 159, pages 211-218.
Crossref
Crossref
Sudipta Bhowmick, Rajesh Ravindran & Nahid Ali. (2014) IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine. BMC Microbiology 14:1.
Crossref
Crossref
Hengameh Firouzmand, Ali Badiee, Ali Khamesipour, Vahid Heravi Shargh, Seyedeh Hoda Alavizadeh, Azam Abbasi & Mahmoud Reza Jaafari. (2013) Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA). Acta Tropica 128:3, pages 528-535.
Crossref
Crossref
Maryam Yazdanian, Arash Memarnejadian, Mehdi Mahdavi, Seyed Mehdi Sadat, Fatemeh Motevali, Rouhollah Vahabpour, Hossein Khanahmad, Seyed Davar Siadat, Mohammad Reza Aghasadeghi & Farzin Roohvand. (2013) Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer. Hepatitis Monthly 13:10.
Crossref
Crossref
Ali Badiee, Vahid Heravi Shargh, Ali Khamesipour & Mahmoud Reza Jaafari. (2013) Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends. Vaccine 31:5, pages 735-749.
Crossref
Crossref
Katrin Färber & Heidrun Moll. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
113
141
.
Saumyabrata Mazumder, Mithun Maji & Nahid Ali. (2011) Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection. PLoS Neglected Tropical Diseases 5:12, pages e1429.
Crossref
Crossref
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, Abdolhossein Rouholamini Najafabadi, Yasaman Taslimi, Rouholah Vahabpour, Fatemeh Torkashvand, Behrooz Vaziri & Sima Rafati. (2011) Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection. Journal of Controlled Release 153:2, pages 154-162.
Crossref
Crossref
Wei-Yun Sheng & Leaf Huang. (2010) Cancer Immunotherapy and Nanomedicine. Pharmaceutical Research 28:2, pages 200-214.
Crossref
Crossref
Rajesh Ravindran, Sudipta Bhowmick, Amrita Das & Nahid Ali. (2010) Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis. BMC Microbiology 10:1.
Crossref
Crossref
Ifeoma OkworJude E Uzonna. (2009) Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature. Immunotherapy 1:5, pages 765-776.
Crossref
Crossref